Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf.
Coherus Oncology (NASDAQ:CHRS) used its presentation at the Citizens Life Sciences Conference to outline its transition into what CEO Denny Lanfear described as an “innovative oncology company focused ...
Wondering if Sun Life Financial at around $86.15 is offering good value today, or if the easy gains are already behind it? This article is here to help you make sense of the current price tag. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results